Related references
Note: Only part of the references are listed.The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles
Rajkumar Reddyrajula et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review
Ankit Jain et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment
Chloe J. Taub et al.
CANCER (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease
A. H. Burstein et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2018)
Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis
T. Kwak et al.
ONCOGENE (2017)
Triazole derivatives and their anti-tubercular activity
Shu Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Salvatore Bongarzone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
AZELIRAGON PHASE 2B SURVIVAL ANALYSIS SUPPORTS BENEFICIAL EFFECTS ON DELAYING TIME TO COGNITIVE DETERIORATION IN PATIENTS WITH MILD ALZHEIMER'S DISEASE
Aaron H. Burstein et al.
Alzheimers & Dementia (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
I2-Catalyzed Oxidative Coupling Reactions of Hydrazones and Amines and the Application in the Synthesis of 1,3,5-Trisubstituted 1,2,4-Triazoles
Zhengkai Chen et al.
ORGANIC LETTERS (2016)
Increased Expression of the Receptor for Advanced Glycation End-Products (RAGE) Is Associated with Advanced Breast Cancer Stage
Maryann Nankali et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment
Mohd W. Nasser et al.
CANCER RESEARCH (2015)
The role of taxanes in triple-negative breast cancer: literature review
Giorgio Mustacchi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Molecular characterization and targeted therapeutic approaches in breast cancer
Angela Toss et al.
BREAST CANCER RESEARCH (2015)
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Aaron H Burstein et al.
BMC Neurology (2014)
The emerging role of exosomes in epithelial mesenchymal-transition in cancer
Laura Jayne Vella
FRONTIERS IN ONCOLOGY (2014)
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents
K. D. Thomas et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Pharmacological significance of triazole scaffold
Rajeev Kharb et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2011)
Triple-negative/basal-like breast cancer: review
Emad A. Rakha et al.
PATHOLOGY (2009)
Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays
HL Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Share Paper
